173 related articles for article (PubMed ID: 7761885)
21. Prevalence and antimicrobial susceptibility pattern of extended-spectrum beta-lactamase-producing Enterobacteriaceae in the United Arab Emirates.
Al-Zarouni M; Senok A; Rashid F; Al-Jesmi SM; Panigrahi D
Med Princ Pract; 2008; 17(1):32-6. PubMed ID: 18059098
[TBL] [Abstract][Full Text] [Related]
22. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
[TBL] [Abstract][Full Text] [Related]
23. Antibiotic coresistance in extended-spectrum-beta-lactamase-producing Enterobacteriaceae and in vitro activity of tigecycline.
Morosini MI; García-Castillo M; Coque TM; Valverde A; Novais A; Loza E; Baquero F; Cantón R
Antimicrob Agents Chemother; 2006 Aug; 50(8):2695-9. PubMed ID: 16870760
[TBL] [Abstract][Full Text] [Related]
24. Canadian survey of antimicrobial resistance in Klebsiella spp. and Enterobacter spp. The Canadian Antimicrobial Resistance Study Group.
Toye BW; Scriver SR; Low DE
J Antimicrob Chemother; 1993 Nov; 32 Suppl B():81-6. PubMed ID: 8150770
[TBL] [Abstract][Full Text] [Related]
25. Bacteremia due to extended-spectrum beta-lactamase-producing Enterobacteriaceae other than Escherichia coli and Klebsiella.
Huang SS; Lee MH; Leu HS
J Microbiol Immunol Infect; 2006 Dec; 39(6):496-502. PubMed ID: 17164953
[TBL] [Abstract][Full Text] [Related]
26. [Investigation of the frequency of extended spectrum beta-lactamases and antibiotic resistance in clinical isolates of Escherichia coli and Klebsiella sp].
Ekşi F; Ozer G; Balci I
Mikrobiyol Bul; 2007 Jul; 41(3):447-52. PubMed ID: 17933257
[TBL] [Abstract][Full Text] [Related]
27. Trends in the frequency of multiple drug-resistant Enterobacteriaceae and their susceptibility to ertapenem, imipenem, and other antimicrobial agents: data from the Study for Monitoring Antimicrobial Resistance Trends 2002 to 2007.
Hoban DJ; Bouchillon SK; Hawser SP; Badal RE
Diagn Microbiol Infect Dis; 2010 Jan; 66(1):78-86. PubMed ID: 19733993
[TBL] [Abstract][Full Text] [Related]
28. Activity of tigecycline tested against a global collection of Enterobacteriaceae, including tetracycline-resistant isolates.
Fritsche TR; Strabala PA; Sader HS; Dowzicky MJ; Jones RN
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):209-13. PubMed ID: 16105566
[TBL] [Abstract][Full Text] [Related]
29. Klebsiella and Enterobacter strains derived from hospital infections. I. Correlation between species, phage type and antibiotic sensitivity.
Nguyen TK; Milch H
Acta Microbiol Acad Sci Hung; 1981; 28(1):67-81. PubMed ID: 7257877
[TBL] [Abstract][Full Text] [Related]
30. Extended spectrum AmpC and metallo-beta-lactamases in Serratia and Citrobacter spp. in a disc approximation assay.
Rizvi M; Fatima N; Rashid M; Shukla I; Malik A; Usman A; Siddiqui S
J Infect Dev Ctries; 2009 May; 3(4):285-94. PubMed ID: 19759492
[TBL] [Abstract][Full Text] [Related]
31. Extended spectrum AmpC and metallo-beta-lactamases in Serratia and Citrobacter spp. in a disc approximation assay.
Rizvi M; Fatima N; Rashid M; Shukla I; Malik A; Usman A; Siddiqui S
J Infect Dev Ctries; 2009 Apr; 3(3):177-86. PubMed ID: 19759472
[TBL] [Abstract][Full Text] [Related]
32. [Profile of antimicrobial resistance of agents causing urinary tract infections in Chilean children. PRONARES surveillance program].
Prado V; Trucco O; Durán C; Mamani R; Royer M;
Rev Med Chil; 2001 Aug; 129(8):877-85. PubMed ID: 11680961
[TBL] [Abstract][Full Text] [Related]
33. Assessment of the clinical significance of production of extended-spectrum beta-lactamases (ESBL) by Enterobacteriaceae.
Henshke-Bar-Meir R; Yinnon AM; Rudensky B; Attias D; Schlesinger Y; Raveh D
Infection; 2006 Apr; 34(2):66-74. PubMed ID: 16703295
[TBL] [Abstract][Full Text] [Related]
34. Occurrence of extended spectrum beta-lactamases among Enterobacteriaceae spp. isolated at a tertiary care institute.
Kumar MS; Lakshmi V; Rajagopalan R
Indian J Med Microbiol; 2006 Jul; 24(3):208-11. PubMed ID: 16912442
[TBL] [Abstract][Full Text] [Related]
35. Transferable drug resistance (R-factor) among the enterobacteriaceae in urinary tract infections: a study at an urban hospital in Bangladesh.
Chowdhury MA; Rahman KM; Miah MR; Haq JA
J Trop Med Hyg; 1994 Jun; 97(3):161-6. PubMed ID: 8007056
[TBL] [Abstract][Full Text] [Related]
36. Prevalence and mechanisms of cephalosporin resistance in Enterobacteriaceae in London and South-East England.
Potz NA; Hope R; Warner M; Johnson AP; Livermore DM;
J Antimicrob Chemother; 2006 Aug; 58(2):320-6. PubMed ID: 16735428
[TBL] [Abstract][Full Text] [Related]
37. Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance.
Shahid M; Malik A; Akram M; Agrawal LM; Khan AU; Agrawal M
Int J Infect Dis; 2008 May; 12(3):256-64. PubMed ID: 17981482
[TBL] [Abstract][Full Text] [Related]
38. [Qnr-type quinolone resistance in extended-spectrum beta-lactamase producing enterobacteria in Abidjan, Ivory Coast].
Guessennd N; Bremont S; Gbonon V; Kacou-Ndouba A; Ekaza E; Lambert T; Dosso M; Courvalin P
Pathol Biol (Paris); 2008; 56(7-8):439-46. PubMed ID: 18926644
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the in vitro activity of 9 antimicrobials against bacterial strains isolated from patients in intensive care units in brazil: MYSTIC Antimicrobial Surveillance Program.
Mendes C; Hsiung A; Kiffer C; Oplustil C; Sinto S; Mimica I; Zoccoli C;
Braz J Infect Dis; 2000 Oct; 4(5):236-44. PubMed ID: 11063555
[TBL] [Abstract][Full Text] [Related]
40. SHV-12 extended spectrum beta-lactamase associated with high-level ceftazidime resistance in Enterobacter cloacae isolated from Thailand.
Tansawai U; Boonkerd N; Polwichai P; Dejsirilert S; Niumsup PR
Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):148-54. PubMed ID: 19323047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]